Tumor-derived exosomes are enriched in ΔNp73, which promotes oncogenic potential in acceptor cells and correlates with patient survival

Human Molecular Genetics

Volumn 23, Issue 2, 2014, Pages 467-478

  Soldevilla, Beatriz ^a   Rodriguez, Marta ^a   Millán, Coral San ^a   Garcia, Vanesa ^a   Fernández Periañez, Rodrigo ^a   Gil Calderón, Beatriz ^a   Martin, Paloma ^a   Garcia Grande, Aránzazu ^a   Silva, Javier ^a   Bonilla, Félix ^a   Dominguez, Gemma ^a,b  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; CARCINOEMBRYONIC ANTIGEN; CD63 ANTIGEN; CD9 ANTIGEN; DELTA NP73 PROTEIN; FLUOROURACIL; FOLINIC ACID; MESSENGER RNA; MICRORNA; NANOPARTICLE; OXALIPLATIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ACCEPTOR CELL; ADJUVANT THERAPY; ANGIOGENESIS ASSAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BRAIN PERICYTE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CELL COMMUNICATION; CELL PROLIFERATION; CELL TYPE; CHEMOREACTIVITY; COLON CARCINOGENESIS; COLORECTAL CANCER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG RESISTANCE; ELECTRON MICROSCOPY; EXOSOME; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HCT116 CELL LINE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; LIMIT OF QUANTITATION; LYMPH NODE METASTASIS; MALE; MOUSE; MTT ASSAY; MULTIMODALITY CANCER THERAPY; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SKIN FIBROBLAST; SURVIVAL RATE; TRANSMISSION ELECTRON MICROSCOPY; TUMOR MICROENVIRONMENT; TUMOR VOLUME; TUMOR XENOGRAFT; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; EXOSOMES; FEMALE; HCT116 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MICE; NUCLEAR PROTEINS; PROGNOSIS; RNA, MESSENGER; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEINS;

EID: 84893188871     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt437     Document Type: Article

References (27)

1. Al-Nedawi, K., Meehan, B., Micallef, J., Lhotak, V., May, L., Guha, A. and Rak, J. (2008). Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat. Cell Biol., 10, 619-624.
2. Mittelbrunn, M. and Sánchez-Madrid, F. (2012). Intercellular communication: diverse structures for exchange of genetic information. Nat. Rev. Mol. Cell Biol., 13, 328-335.
3. Nilsson, J., Skog, J., Nordstrand, A., Baranov, V., Mincheva-Nilsson, L., Breakefield, X.O. and Widmark, A. (2009). Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br. J. Cancer, 100, 1603-1607.
4. Viaud, S., Théry, C., Ploix, S., Tursz, T., Lapierre, V., Lantz, O., Zitvogel, L. and Chaput, N. (2010) Dendritic cell-derived exosomes for cancer immunotherapy: what's next? Cancer Res., 70, 1281-1285.
5. Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., Garcia-Santos, G., Ghajar, C. et al. (2012). Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype throughMET.Nat. Med., 18, 883-891.
6. Zhuang, G., Wu, X., Jiang, Z., Kasman, I., Yao, J., Guan, Y., Oeh, J., Modrusan, Z., Bais, C., Sampath, D. et al. (2012). Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J., 31, 3513-3523.
7. Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J.J. and Lötvall, J.O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol., 9, 654-659.
8. Taylor, D.D. and Gerçel-Taylor, C. (2005). Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br. J. Cancer, 92, 305-311.
9. Skog, J., Würdinger, T., van Rijn, S., Meijer, D.H., Gainche, L., Sena-Esteves, M., Curry, W.T. Jr, Carter, B.S., Krichevsky, A.M. and Breakefield, X.O. (2008). Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol., 10, 1470-1476.
10. Mittelbrunn, M., Gutiérrez-Vázquez, C., Villarroya-Beltri, C., González, S., Sánchez-Cabo, F., González, M.Á ., Bernad, A. and Sánchez-Madrid, F. (2011) Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat. Commun., 2, 282.
11. Montecalvo, A., Larregina, A.T., Shufesky, W.J., Stolz, D.B., Sullivan, M.L.G., Karlsson, J.M., Baty, C.J., Gibson, G.A., Erdos, G., Wang, Z. et al. (2012). Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood, 119, 756-766.
12. Koga, K., Matsumoto, K., Akiyoshi, T., Kubo, M., Yamanaka, N., Tasaki, A., Nakashima, H., Nakamura, M., Kuroki, S., Tanaka, M. et al. (2005). Purification, characterization and biological significance of tumor-derived exosomes. Anticancer Res., 25, 3703-3707.
13. Baj-Krzyworzeka, M., Szatanek, R., Weglarczyk, K., Baran, J., Urbanowicz, B., Brański, P., Ratajczak, M.Z. and Zembala, M. (2006). Tumour-derived microvesicles carry several surface determinants andmRNAof tumour cells and transfer some of these determinants to monocytes. Cancer Immunol. Immunother., 55, 808-818.
14. Grange, C., Tapparo, M., Collino, F., Vitillo, L., Damasco, C., Deregibus, M.C., Tetta, C., Bussolati, B. and Camussi, G. (2011). Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res., 71, 5346-5356.
15. Soldevilla, B., Diaz, R., Silva, J., Campos-Martin, Y.,Muñoz, C., Garcia, V., Garcia, J.M., Peña, C., Herrera, M., Rodriguez, M. et al. (2011). Prognostic impact of DTAp73 isoform levels and their target genes in colon cancer patients. Clin. Cancer Res., 17, 6029-6039.
16. Zaika, A.I., Slade, N., Erster, S.H., Sansome, C., Joseph, T.W., Pearl, M., Chalas, E. and Moll, U.M. (2002). Deltanp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J. Exp. Med., 196, 765-780.
17. Fillippovich, I., Sorokina, N., Gatei, M., Haupt, Y., Hobson, K., Moallem, E., Spring, K., Mould, M., McGuckin, M.A., Lavin, M.F. et al. (2001). Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53. Oncogene, 20, 514-522.
18. Stiewe, T., Zimmermann, S., Frilling, A., Esche, H. and Pützer, B.M. (2002). Transactivation-deficient DeltaTA-p73 acts as an oncogene. Cancer Res., 62, 3598-3602.
19. Lin, Y.-L., Sengupta, S., Gurdziel, K., Bell, G.W., Jacks, T. and Flores, E.R. (2009) P63 and p73 transcriptionally regulate genes involved in DNA repair. PLoS Genet., 5, e1000680.
20. Ta, L.E., Low, P.A. and Windebank, A.J. (2009) Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli. Mol. Pain, 5, 9.
21. Silva, J., Garcia, V., Rodriguez, M., Compte, M., Cisneros, E., Veguillas, P., Garcia, J.M., Dominguez, G., Campos-Martin, Y., Cuevas, J. et al. (2012). Analysis of exosome release and its prognostic value in human colorectal cancer. Genes Chromosomes Cancer, 51, 409-418.
22. Wilhelm, M.T., Rufini, A., Wetzel, M.K., Tsuchihara, K., Inoue, S., Tomasini, R., Itie-Youten, A., Wakeham, A., Arsenian-Henriksson, M., Melino, G. et al. (2010). Isoform-specific p73 knockout mice reveal a novel role for delta Np73 in the DNA damage response pathway. Genes Dev., 24, 549-560.
23. McAllister, S.S., Gifford, A.M., Greiner, A.L., Kelleher, S.P., Saelzler, M.P., Ince, T.A., Reinhardt, F., Harris, L.N., Hylander, B.L., Repasky, E.A. et al. (2008). Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell, 133, 994-1005.
24. Xing, F., Saidou, J. and Watabe, K. (2010). Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front. Biosci., 15, 166-179.
25. Pruitt, F.L., He, Y., Franco, O.E., Jiang, M., Cates, J.M. and Hayward, S.W. (2012) Cathepsin D acts as an essential mediator to promote malignancy of benign prostatic epithelium. Prostate, 10.1002/pros.22589.
26. Aguilera, O., Peña, C., Garcia, J.M., Larriba, M.J., Ordóñez-Morán, P., Navarro, D., Barbáchano, A., López de Silanes, I., Ballestar, E., Fraga, M.F. et al. (2007). The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells. Carcinogenesis, 28, 1877-1884.
27. Savina, A., Vidal, M. and Colombo, M.I. (2002). The exosome pathway in K562 cells is regulated by Rab11. J. Cell. Sci., 115, 2505-2515.